Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Swift Scanlan, Theresa ^a   Smith, Christopher T ^a   Bardowell, Sabrina A ^a   Boettiger, Charlotte A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CATECHOLAMINES; CELL LINE, TUMOR; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE;

EID: 84892712317     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-5     Document Type: Article

References (74)

1. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Mannisto PT, Kaakkola S, Pharmacol Rev 1999 51 593 628 10581325
2. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD, Cancer Res 1997 57 5493 5497 9407957 (Pubitemid 28006754)
3. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, et al. Hum Mol Genet 2005 14 135 143 15537663 (Pubitemid 40123469)
4. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D, Science 2003 299 1240 1243 10.1126/science.1078546 12595695 (Pubitemid 36237467)
5. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR, Proc Natl Acad Sci U S A 2001 98 6917 6922 10.1073/pnas.111134598 11381111 (Pubitemid 32538317)
6. Potential role of membrane-bound COMT gene polymorphisms in female depression vulnerability. Hatzimanolis A, Vitoratou S, Mandelli L, Vaiopoulos C, Nearchou FA, Stefanis CN, Serretti A, Stefanis NC, J Affect Disord 2013 148 316 322 10.1016/j.jad.2012.12.018 23351565
7. Association between the functional variant of the catechol-O- methyltransferase (COMT) gene and type 1 alcoholism. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynanen OP, Koulu M, Karvonen MK, et al. Mol Psychiatry 1999 4 286 289 10.1038/sj.mp.4000509 10395222 (Pubitemid 29292182)
8. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM, Am J Med Genet 1997 74 439 442 10.1002/(SICI)1096-8628(19970725)74:4<439: :AID-AJMG16>3.0.CO;2-J 9259381 (Pubitemid 27349382)
9. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity val allele with adhd impulsive-hyperactive phenotype. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein RP, Am J Med Genet 1999 88 497 502 10.1002/(SICI)1096-8628(19991015)88:5<497: :AID-AJMG12>3.0.CO;2-F 10490706 (Pubitemid 29485076)
10. Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. Männistö P, Kaakkola S, Pharmacol Toxicol 1990 66 317 323 10.1111/j.1600-0773.1990.tb00756.x 2196554 (Pubitemid 20330491)
11. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Weinshilboum RM, Raymond FA, Am J Hum Genet 1977 29 125 135 848488 (Pubitemid 8070429)
12. Human liver catechol-O-methyltransferase pharmacogenetics. Boudikova B, Szumlanski C, Maidak B, Weinshilboum R, Clin Pharmacol Ther 1990 48 381 389 10.1038/clpt.1990.166 2225698 (Pubitemid 20362271)
13. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM, Pharmacogenetics 1996 6 243 250 10.1097/00008571-199606000-00007 8807664 (Pubitemid 26226317)
14. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J, Biochemistry 1995 34 4202 4210 10.1021/bi00013a008 7703232
15. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr AR, Deaton A, Andrews R, James KD, et al. Nature 2010 464 1082 1086 10.1038/nature08924 20393567
16. TM4 microarray software suite. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J, Methods Enzymol 2006 411 134 193 16939790
17. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Karoum F, Chrapusta SJ, Egan MF, J Neurochem 1994 63 972 979 7914228
18. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions. Laatikainen LM, Sharp T, Harrison PJ, Tunbridge EM, PLoS One 2013 8 61839 10.1371/journal.pone. 0061839 23613951
19. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T, Nanko S, Murray RM, McGuffin P, Owen M, et al. Psychiatr Genet 1997 7 97 101 10.1097/00041444-199723000-00001 9323320 (Pubitemid 27450083)
20. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Nackley A, Shabalina S, Tchivileva I, Satterfield K, Korchynskyi O, Makarov S, Maixner W, Diatchenko L, Science 2006 314 1930 1933 10.1126/science.1131262 17185601 (Pubitemid 46026115)
21. Low enzymatic activity haplotypes of the human catechol-O- methyltransferase gene: enrichment for marker SNPs. Nackley AG, Shabalina SA, Lambert JE, Conrad MS, Gibson DG, Spiridonov AN, Satterfield SK, Diatchenko L, PLoS One 2009 4 5237 10.1371/journal.pone.0005237 19365560
22. Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Tunbridge EM, Harrison PJ, Warden DR, Johnston C, Refsum H, Smith AD, American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics 2008 147B 996 999 10.1002/ajmg.b.30700
23. MTHFR 677C T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val Met. Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, White T, Clark VP, Fries J, Andreasen NC, et al. Proc Natl Acad Sci U S A 2008 105 17573 17578 10.1073/pnas.0803727105 18988738
24. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH, Halsted CH, Goff DC, American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics 2008 147B 990 995 10.1002/ajmg.b.30684
25. COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: an exploratory study. Kontis D, Theochari E, Fryssira H, Kleisas S, Sofocleous C, Andreopoulou A, Kalogerakou S, Gazi A, Boniatsi L, Chaidemenos A, et al. Neurosci Lett 2013 537 17 22 23353103
26. Green tea consumption and breast cancer risk in Japanese women: a case-control study. Iwasaki M, Mizusawa J, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Tsugane S, Nutr Cancer 2014 66 57 67 10.1080/01635581. 2014.847963 24274352
27. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. Gallicchio L, Berndt SI, McSorley MA, Newschaffer CJ, Thuita LW, Argani P, Hoffman SC, Helzlsouer KJ, BMC Cancer 2006 6 173 10.1186/1471-2407-6-173 16808847 (Pubitemid 44202808)
28. Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Yu CP, Wu MH, Chou YC, Yang T, You SL, Chen CJ, Sun CA, Anticancer Res 2007 27 1727 1732 17595805 (Pubitemid 46807266)
29. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Tunbridge EM, Weickert CS, Kleinman JE, Herman MM, Chen J, Kolachana BS, Harrison PJ, Weinberger DR, Cereb Cortex 2007 17 1206 1212 16835293 (Pubitemid 46598863)
30. Age modulates the effect of COMT genotype on delay discounting behavior. Smith CT, Boettiger CA, Psychopharmacology (Berl) 2012 222 609 617 10.1007/s00213-012-2653-9 22349272
31. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Cancer Res 1998 58 2107 2110 9605753 (Pubitemid 28232895)
32. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Harrison PJ, Tunbridge EM, Neuropsychopharmacology 2007 33 3037 3045 17805313
33. Stress-related methylation of the catechol-O-methyltransferase Val158 allele predicts human prefrontal cognition and activity. Ursini G, Bollati V, Fazio L, Porcelli A, Iacovelli L, Catalani A, Sinibaldi L, Gelao B, Romano R, Rampino A, et al. J Neurosci 2011 31 6692 6698 10.1523/JNEUROSCI.6631-10.2011 21543598
34. Affect-modulated startle: interactive influence of catechol-O- methyltransferase Val158Met genotype and childhood trauma. Klauke B, Winter B, Gajewska A, Zwanzger P, Reif A, Herrmann MJ, Dlugos A, Warrings B, Jacob C, Mühlberger A, PLoS One 2012 7 39709 10.1371/journal.pone.0039709 22745815
35. COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence. Schellekens AFA, Franke B, Ellenbroek B, Cools A, de Jong CAJ, Buitelaar JK, Verkes R-J, Addict Biol 2013 18 344 356 10.1111/j.1369-1600.2012.00438.x 22509987
36. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-O-methyltransferase Val158Met polymorphism. Kolassa I-T, Kolassa S, Ertl V, Papassotiropoulos A, De Quervain DJF, Biol Psychiatry 2010 67 304 308 10.1016/j.biopsych.2009.10.009 19944409
37. Catechol-O-methyltransferase (COMT) val158met polymorphism as a risk factor for PTSD after urban violence. Valente NLM, Vallada H, Cordeiro Q, Bressan RA, Andreoli SB, Mari JJ, Mello MF, J Mol Neurosci 2011 43 516 523 10.1007/s12031-010-9474-2 21080103
38. The catechol omethyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD). Wagner S, Baskaya Ö Anicker N, Dahmen N, Lieb K, Tadić A, Acta Psychiatr Scand 2010 122 110 117 10.1111/j.1600-0447.2009.01501.x 19906087
39. Alcohol and the methylome: design and analysis considerations for research using human samples. Harlaar N, Hutchison KE, Drug Alcohol Depend 2013 133 305 316 10.1016/j.drugalcdep.2013.07.026 23968814
40. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R, Cancer Res 2003 63 3101 3106 12810635 (Pubitemid 36735859)
41. Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population. Li K, Li W, Zou H, Tumour Biol in press
42. The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population. Tian C, Liu L, Yang X, Wu H, Ouyang Q, Tumour Bio in press
43. Catechol-methyltransferase: characteristics, polymorphisms and role in breast cancer. Yager JD, Drug Discov Today Dis Mech 2012 9 41 e46 23734165
44. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. He XF, Wei W, Li SX, Su J, Zhang Y, Ye XH, Liu Y, Wang W, Mol Biol Rep 2012 39 6811 6823 10.1007/s11033-012-1506-2 22297695
45. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. Am J Hum Genet 2004 75 807 821 10.1086/425589 15457404 (Pubitemid 39390488)
46. The ability of four catechol estrogens of 17beta-estradiol and estrone to induce DNA adducts in Syrian hamster embryo fibroblasts. Yagi E, Barrett JC, Tsutsui T, Carcinogenesis 2001 22 1505 1510 10.1093/carcin/22.9.1505 11532873 (Pubitemid 32898708)
47. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S, PLoS One 2011 6 21102 10.1371/journal.pone.0021102 21738611
48. Dietary and Lifestyle Factors of DNA Methylation. Lim U, Song M-A, Methods Mol Biol 2012 863 359 376 10.1007/978-1-61779-612-8-23 22359306
49. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. McLean SA, Diatchenko L, Lee YM, Swor RA, Domeier RM, Jones JS, Jones CW, Reed C, Harris RE, Maixner W, et al. J Pain 2011 12 101 107 10.1016/j.jpain.2010.05.008 20688576
50. COMT Val158Met x SLC6A4 5-HTTLPR interaction impacts on gray matter volume of regions supporting emotion processing. Radua J, El-Hage W, Monte GC, Gohier B, Tropeano M, Phillips ML, Surguladze SA, Soc Cogn Affect Neurosci in press
51. Effects of COMT polymorphisms on brain function and behavior in health and disease. Witte AV, Floel A, Brain Res Bull 2012 88 418 428 10.1016/j.brainresbull.2011.11.012 22138198
52. Differential genetic and epigenetic regulation of catechol-O- methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder. Norrholm SD, Jovanovic T, Smith AK, Binder E, Klengel T, Conneely K, Mercer KB, Davis JS, Kerley K, Winkler J, et al. Front Behav Neurosci 2013 7 30 23596403
53. Association of COMT genotypes with S-COMT promoter methylation in growth-discordant monozygotic twins and healthy adults. Schreiner F, El-Maarri O, Gohlke B, Stutte S, Nuesgen N, Mattheisen M, Fimmers R, Bartmann P, Oldenburg J, Woelfle J, BMC Med Genet 2011 12 115 10.1186/1471-2350-12-115 21884617
54. Genome-wide epigenetic regulation by early-life trauma. Labonte B, Suderman M, Maussion G, Navaro L, Yerko V, Mahar I, Bureau A, Mechawar N, Szyf M, Meaney MJ, et al. Arch Gen Psychiatry 2012 69 722 731 22752237
55. Phenotypic plasticity and the epigenetics of human disease. Feinberg AP, Nature 2007 447 433 440 10.1038/nature05919 17522677 (Pubitemid 46816750)
56. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Murphy BC, O'Reilly RL, Singh SM, American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics 2005 133B 37 42 10.1002/ajmg.b.30134 (Pubitemid 40175612)
57. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Abdolmaleky HM, Cheng K, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Hum Mol Genet 2006 15 3132 3145 10.1093/hmg/ddl253 16984965 (Pubitemid 44607800)
58. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari M-R, Ahmadkhaniha H, Thiagalingam S, Abdolmaleky HM, J Psychiatr Res 2011 45 1432 1438 10.1016/j.jpsychires.2011.06.013 21820670
59. Hollingshead A, Four Factor Index of Social Status New Haven: Yale University 1975
60. Development of the alcohol Use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M, Addiction (Abingdon, England) 1993 88 791 804 10.1111/j.1360-0443.1993.tb02093.x (Pubitemid 23194530)
61. Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. Boettiger CA, Mitchell JM, Tavares VC, Robertson M, Joslyn G, D'Esposito M, Fields HL, J Neurosci 2007 27 14383 14391 10.1523/JNEUROSCI.2551-07.2007 18160646
62. Vimentin DNA methylation predicts survival in breast cancer. Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T, Breast Cancer Res Treat 2013 137 383 396 10.1007/s10549-012-2353-5 23239149
63. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ, Nucleic Acids Res 2007 35 119 10.1093/nar/gkm662 17855397 (Pubitemid 350019244)
64. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D, Proc Natl Acad Sci USA 2005 102 15785 15790 10.1073/pnas.0507816102 16243968 (Pubitemid 41552820)
65. High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S, Holzgreve W, Zhong XY, Mol Cancer Res 2008 6 1702 1709 10.1158/1541-7786.MCR-08-0262 19010818
66. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J R Stat Soc Ser B Methodol 1995 57 289 300
67. Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. Ponomarev I, Wang S, Zhang L, Harris RA, Mayfield RD, J Neurosci 2012 32 1884 1897 10.1523/JNEUROSCI.3136-11.2012 22302827
68. Status variations in stress exposure: implications for the interpretation of research on race, socioeconomic status, and gender. Turner RJ, Avison WR, J Health Soc Behav 2003 44 488 505 10.2307/1519795 15038145 (Pubitemid 38497205)
69. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Zhu Z-Z, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, Yang AS, Vokonas P, Lissowska J, Fustinoni S, et al. Int J Epidemiol 2012 41 126 139 10.1093/ije/dyq154 20846947
70. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. Bönsch D, Lenz B, Reulbach U, Kornhuber J, Bleich S, J Neural Transm 2004 111 1611 1616 10.1007/s00702-004-0232-x 15565495 (Pubitemid 40064478)
71. Association of dietary and genetic factors related to one-carbon metabolism with global methylation level of leukocyte DNA. Ono H, Iwasaki M, Kuchiba A, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Ohnami S, Sakamoto H, et al. Cancer Sci 2012 103 2159 2164 10.1111/cas.12013 22957669
72. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, Vishwanatha JK, Santella RM, Morabia A, Epigenetics 2011 6 623 629 10.4161/epi.6.5.15335 21739720
73. Array-based profiling of DNA methylation changes associated with alcohol dependence. Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W, Gelernter J, Alcohol Clin Exp Res 2013 37 108 E115 22924764
74. Profiling of childhood adversity-associated DNA methylation changes in alcoholic patients and healthy controls. Zhang H, Wang F, Kranzler HR, Zhao H, Gelernter J, PLoS One 2013 8 65648 10.1371/journal.pone.0065648 23799031